Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Nov 15, 2021; 13(11): 1680-1695
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1680
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1680
Table 2 Liver tumors identified in chronic liver diseases
Liver disease and main pathogenesis | Tumor type |
Genetic or metabolic syndromes | |
Hereditary tyrosinemia type 1[80-83] | HCC |
GSD type 1, 3, 4 | HA, HCC, HB |
Alagille syndrome | HCC, regenerative nodule |
Other familial cholestatic syndromes | HCC |
NAFLD | HCC |
α-1 antitrypsin deficiency | HCC |
Infections | |
HBV | HCC |
HCV | HCC |
Vascular | |
Abernethy | FNH, HCC, HA |
Noncirrhotic portal hypertension | NRH |
Congenital portosystemic shunt | HCC, HB |
Cirrhosis and cholestatic conditions | |
Biliary atresia | HCC, FNH, pseudotumor |
Autoimmune hepatitis | HCC |
Wilson disease | HCC |
Congenital hepatic fibrosis | HCC |
Cryptogenic cirrhosis | HCC |
- Citation: Sintusek P, Phewplung T, Sanpavat A, Poovorawan Y. Liver tumors in children with chronic liver diseases. World J Gastrointest Oncol 2021; 13(11): 1680-1695
- URL: https://www.wjgnet.com/1948-5204/full/v13/i11/1680.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i11.1680